Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection

Jan Keppel Hesselink
  • International Medical Case Reports Journal, September 2013, Taylor & Francis
  • DOI: 10.2147/imcrj.s51572

Idiopathic neuropathy and pain can be treated with the supplement palmitoylethanolamide

What is it about?

Idiopathic polyneuropathy patients often suffer from chronic neuropathic pain. The supplement palmitoylethanolamide is easy to use and should be considered more often. Recommended dose: 3 times 400 mg capsules daily.

Why is it important?

Because many analgesics have dose-dependent side effects limiting its use in CIAP patients, and PEA has not!


jan keppel hesselink
Institute Neuropathic Pain

Palmitoylethanolamide should become a first step analgesic in chronic pain and should be used more often as it also has opioid sparing effects in chronic pain!

Read Publication

The following have contributed to this page: jan keppel hesselink